Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Effects of Psilocybin in Post-Treatment Lyme Disease


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05305105

Organisation Name: Johns Hopkins University

Overal Status: Enrolling by invitation

Start Date: July 1, 2022

Last Update: August 3, 2022

Lead Sponsor: Johns Hopkins University

Brief Summary: This study will examine the effects of psilocybin on Lyme disease symptom burden and quality of life in people with Post-Treatment Lyme Disease (PTLD).

Conditions:
  • Post-Treatment Lyme Disease
  • Chronic Lyme Disease
  • Lyme Disease, Chronic


Total execution time in seconds: 0.37335610389709